The Enterprise Value as of June 2026 (TTM) for CASI Pharmaceuticals, Inc. (CASI) is 18.28M

According to CASI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.28M. This represents a change of -55.60% compared to the average of 41.17M of the last 4 quarters.

CASI Pharmaceuticals, Inc. (CASI) Historical Enterprise Value (quarterly & annually)

How has CASI Enterprise Value performed in the past?

The mean historical Enterprise Value of CASI Pharmaceuticals, Inc. over the last ten years is 120.42M. The current 18.28M Enterprise Value has changed 1.42% with respect to the historical average. Over the past ten years (40 quarters), CASI's Enterprise Value was at its highest in in the June 2018 quarter at 643.31M. The Enterprise Value was at its lowest in in the December 2022 quarter at -21678851.25.

CASI Pharmaceuticals, Inc. (CASI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CASI Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CASI Pharmaceuticals, Inc. (CASI) Average Enterprise Value

How has CASI Enterprise Value performed in the past?

The current Enterprise Value of CASI Pharmaceuticals, Inc. (CASI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CASI Pharmaceuticals, Inc. (CASI) Enterprise Value vs. Peers

How is CASI’s Enterprise Value compared to its peers?

CASI Pharmaceuticals, Inc.’s Enterprise Value is less than Clearside Biomedical, Inc. (56.30M), greater than Cingulate Inc. (8.89M), less than Entero Therapeutics, Inc. (19.92M), greater than Curis, Inc. (-8118049.00), less than Pelthos Therapeutics Inc. (38.54M), greater than NuCana plc (-12018987.12), less than Palisade Bio, Inc. (164.19M), less than Allarity Therapeutics, Inc. (24.44M), greater than Kairos Pharma, Ltd. (5.75M), less than Lisata Therapeutics, Inc. (19.36M),

Build a custom stock screener for CASI Pharmaceuticals, Inc. (CASI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CASI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CASI Pharmaceuticals, Inc. (CASI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CASI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.